The term 'muscle quality' comes up often in clinical and research settings, yet it remains one of the least clearly defined concepts in musculoskeletal medicine. For a long time, clinicians focused mainly on muscle mass: how much muscle a person has. But mass alone does not tell the full story. Two people with the same amount of muscle can have very different levels of strength, endurance, and physical function. Thus, muscle quality as a concept has emerged.

There is no single agreed-upon definition of muscle quality. Research studies take two main approaches. About 70% use a functional approach, measuring strength relative to body size or mass. The other 30% use a morphological approach, which looks at the physical makeup of the muscle tissue itself. These two approaches measure different things, carry different clinical implications, and do not always point in the same direction. Both are covered here, along with what tools are available, when each approach works best, and why the field needs better standardization.

Sarcopenia research has long relied on muscle mass to identify people at risk. But mass-based criteria miss many cases. When traditional thresholds are used, as few as 0.3% of people in some study groups meet the criteria for sarcopenia. When a more sensitive marker is used, such as the ratio of intracellular water to lean mass, that number rises to 8.2%. The people identified by this broader approach also show real signs of functional impairment. This suggests that relying on mass alone leaves many at-risk individuals undetected.

Several processes explain why. Fat can infiltrate muscle tissue, reducing its ability to produce force and impairing insulin sensitivity, even when total muscle volume looks normal. Mitochondrial function can decline, reducing endurance and aerobic capacity. The distribution of muscle fiber types can shift in ways that lower both peak power and sustained output. None of these changes show up reliably in a mass measurement. That is why quality-based assessment is needed.

 The Functional Approach

Functional measures of muscle quality express how much force or power a muscle produces relative to its size. Three approaches have been well validated in the research literature:

• Grip strength divided by appendicular lean mass: practical and easy to use in outpatient or community settings
• Knee extension strength normalized to leg lean mass: useful for lower-extremity assessment and fall risk screening
• Power output from timed sit-to-stand tests: captures both strength and speed, and is strongly linked to functional independence

Results vary by population and the outcome being studied, which matters when setting clinical cutpoints. In fall prevention research, higher functional muscle quality of the lower body has been linked to a 94.5% reduction in fall risk per unit improvement. This kind of finding highlights why it is important to select measures that match the target outcome.

 The Morphological Approach

 Imaging-Based Measures

 CT-based muscle radiodensity is the most thoroughly studied morphological measure. Lower attenuation values indicate more fat and connective tissue within the muscle. This measure predicts outcomes beyond what mass can capture. A composite index combining strength and radiodensity predicts cancer mortality better compared to mass-based measures alone. Quantitative MRI can also assess muscle tissue in detail using markers like T2 relaxation time, fractional anisotropy, and fascicle length. These add predictive value for strength beyond what mass measurement provides, though MRI is mainly used in research settings due to cost and access.

Ultrasound echo intensity offers a practical, radiation-free way to assess muscle composition in clinical settings. Higher echo intensity means more fat and fibrous tissue in the muscle, and it correlates moderately with lower strength in older adults. This relationship holds in middle-aged and older populations but not in healthy young adults, where fat infiltration is rarely present. Using echo intensity in the wrong population can produce misleading results.

Non-Imaging Measures

 Phase angle, derived from bioelectrical impedance analysis, reflects the health and integrity of cell membranes. It correlates moderately with CT radiodensity and correctly classifies low radiodensity with good accuracy. This makes it a useful screening option when imaging is not available. Muscular adipose tissue content, measured by imaging, shows strong inverse correlations with strength. Fascicle pennation angle, measurable by ultrasound, also correlates with strength by capturing how fiber angle affects force output.

For low-resource settings, simple body measurements such as mid-arm muscle circumference, corrected arm muscle area, and BMI-adjusted calf circumference can still provide useful information. When combined into composite muscle quality indices, these markers are linked to a 32 to 44% reduction in hospitalization risk per unit increase. Metabolomic markers related to protein intake and muscle contraction also show associations with muscle quality, but these are not yet ready for routine clinical use.

Clinical and Research Implications

 Without a standard definition, muscle quality research is hard to compare across studies. Prevalence estimates, risk thresholds, and treatment targets all change depending on which measure is used. In surgical oncology, the value of preoperative muscle quality is well recognized, but no standard cutoff values exist for routine use. In geriatric medicine and rehabilitation, the concept is widely referenced, but inconsistent measurement makes it difficult to apply research findings in practice.

The right tool also depends on who is being assessed and what outcome matters. A measure that works well for predicting falls in older community-dwellers may not apply to cancer prognosis or surgical risk. Using the wrong tool can produce inaccurate classifications and missed cases. There is no single gold standard, and there is unlikely to be one given how many dimensions the concept covers. The practical solution is to select measures based on the population, the clinical question, and what technology is available.

A tiered approach makes sense. Strength-to-mass ratios work well for routine screening in most adult populations. BIA phase angle and ultrasound echo intensity add morphological detail for higher-risk groups, especially older adults. CT radiodensity and quantitative MRI are best reserved for oncology, research, and cases where tissue-level detail is needed for clinical decisions. Groups like the European Working Group on Sarcopenia in Older People (EWGSOP) are working toward better standards, but significant variation in methods across studies means this work is still ongoing.

Conclusion

 Muscle quality is a clinically meaningful concept with a growing set of measurement tools, including functional ratios, imaging-based composition measures, proxy markers, and emerging biochemical indicators. Each has defined strengths, limitations, and populations where it works best. For clinicians, the key is matching the tool to the context: lower-body functional measures for fall prevention, CT radiodensity for oncologic risk, BIA phase angle when imaging is not available, and anthropometric indices when resources are limited. No single measure is sufficient on its own.

For researchers, standardization is the top priority. The variation in definitions and methods currently found across the literature makes it hard to build a cumulative, comparable body of evidence. Progress will require collaboration across disciplines and agreement on core measurement protocols. As populations age and muscle-related health problems grow, getting this right is not just an academic concern. It is a practical necessity.

Recommended Reading

De Lucena Alves CP, De Almeida SB, Lima DP, Neto PB, Miranda AL, Manini T et al (2023)    Muscle quality in older adults: a scoping review. J Am Med Dir Assoc 24:462-467.e12.

 Costa-Pereira JP, Cristina Gonzalez M, Cruz-Jentoft AJ, Goodpaster BH, Daly RM, Fayh APT, Heymsfield SB, Prado CM. "Muscle quality": rethinking an imprecise term. Eur Geriatr Med. 2026 Feb;17(1):11-24.

 Kuschel LB, Sonnenburg D, Engel T. Factors of Muscle Quality and Determinants of Muscle Strength: A Systematic Literature Review. Healthcare (Basel). 2022 Oct 3;10(10):1937.

Costa Pereira JPD, Rebouças AS, Prado CM, Gonzalez MC, Cabral PC, Diniz ADS, Trussardi Fayh AP, Silva FM. Phase angle as a marker of muscle quality: A systematic review and meta-analysis. Clin Nutr. 2024 Dec;43(12):308-326.